Federated Hermes’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Buy |
7,221
+4,343
| +151% | +$14.8K | ﹤0.01% | 1693 |
|
|
2025
Q1 | $11.5K | Sell |
2,878
-4,770
| -62% | -$19.1K | ﹤0.01% | 1790 |
|
|
2024
Q4 | $49.6K | Buy |
7,648
+624
| +9% | +$4.05K | ﹤0.01% | 1666 |
|
|
2024
Q3 | $38.9K | Buy |
7,024
+2,991
| +74% | +$16.6K | ﹤0.01% | 1691 |
|
|
2024
Q2 | $22.5K | Sell |
4,033
-154
| -4% | -$859 | ﹤0.01% | 1707 |
|
|
2024
Q1 | $28.1K | Buy |
4,187
+191
| +5% | +$1.28K | ﹤0.01% | 1689 |
|
|
2023
Q4 | $36.4K | Buy |
+3,996
| New | +$36.4K | ﹤0.01% | 1687 |
|